Transcription factor AP2 enhances malignancy of non-small cell lung cancer through upregulation of USP22 gene expression
Transcription factor AP2 enhances malignancy of non-small cell lung cancer through upregulation of USP22 gene expression is a paper indexed in PICO Portal from OpenAlex.
How many citations does Transcription factor AP2 enhances malignancy of non-small cell lung cancer through upregulation of USP22 gene expression have?
Transcription factor AP2 enhances malignancy of non-small cell lung cancer through upregulation of USP22 gene expression has 26 citations in the OpenAlex counts PICO Portal stores.
When was Transcription factor AP2 enhances malignancy of non-small cell lung cancer through upregulation of USP22 gene expression published?
Transcription factor AP2 enhances malignancy of non-small cell lung cancer through upregulation of USP22 gene expression has 2022 year in the PICO Portal index.
What is the open-access status of Transcription factor AP2 enhances malignancy of non-small cell lung cancer through upregulation of USP22 gene expression?
Transcription factor AP2 enhances malignancy of non-small cell lung cancer through upregulation of USP22 gene expression has gold oa status in the PICO Portal index.
What is the DOI of Transcription factor AP2 enhances malignancy of non-small cell lung cancer through upregulation of USP22 gene expression?
The DOI for Transcription factor AP2 enhances malignancy of non-small cell lung cancer through upregulation of USP22 gene expression is on the source record.
What is the PMID of Transcription factor AP2 enhances malignancy of non-small cell lung cancer through upregulation of USP22 gene expression?
The PMID for Transcription factor AP2 enhances malignancy of non-small cell lung cancer through upregulation of USP22 gene expression is on the source record.
What is the OpenAlex record for Transcription factor AP2 enhances malignancy of non-small cell lung cancer through upregulation of USP22 gene expression?
The OpenAlex for Transcription factor AP2 enhances malignancy of non-small cell lung cancer through upregulation of USP22 gene expression is on the source record.